Clinical Trial Update: High-dose Vitamin D3 in Pancreas Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of high-dose Vitamin D3 in pancreas cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Medical University of Graz | Conditions: Pancreas Cancer, Vitamin D Deficiency | Phase 3 | Status: TERMINATED